Veklury (remdesivir)
Ended Awarded Last action
- Contract number
- 36C25621F0110
- Awardee
-
Gilead Sciences Inc. UEI FPJMGUK1BYH8
- Awarding agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $77,850
Award facts
- Contract value 100% obligated
- $77,850.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Foster City, CA 94404, USA
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
About this award
This is a Delivery Order awarded by the Veterans Integrated Service Network (VISN) 16 of the U.S. Department of Veterans Affairs (VA) to Gilead Sciences Inc. (doing business as Gilead), a prominent biopharmaceutical company. The contract is for the procurement of Veklury (remdesivir), a COVID-19 treatment medication. The contract has a firm fixed price of $77,850.00 and an ultimate completion date of July 18, 2021. The award is not associated with any set-aside designations. Gilead is the prime contractor for this delivery order, which was placed under the GSA Schedule 61-IB for Pharmaceuticals and Drugs. This contract demonstrates Gilead's strategic role in supplying critical pharmaceutical products, particularly antiviral treatments, to federal healthcare programs such as the VA.
Quick answers
Who was awarded contract 36C25621F0110?
36C25621F0110 was awarded to Gilead Sciences Inc. by Veterans Integrated Service Network 16 (Veterans Health Administration) on February 8, 2021.
How much is contract 36C25621F0110 worth?
The government has obligated $77,850 on 36C25621F0110.
Is contract 36C25621F0110 an order under another contract?
Yes. 36C25621F0110 is a delivery order under V797D70252, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25621F0110 competed?
The extent of competition for 36C25621F0110 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award